Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib

BACKGROUND: Impressive survival outcome of our previous study in unresectable hepatocellular carcinoma (HCC) patients undergoing yttrium-90 glass microspheres transarterial radioembolization (TARE) with/without sorafenib according to individuals’ disease burden, i.e., intrahepatic tumor load (IHT) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Teyateeti, Ajalaya, Mahvash, Armeen, Long, James, Abdelsalam, Mohamed, Avritscher, Rony, Kaseb, Ahmed, Odisio, Bruno, Ravizzini, Gregory, Surasi, Devaki, Teyateeti, Achiraya, Macapinlac, Homer, Kappadath, Srinivas Cheenu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704272/
https://www.ncbi.nlm.nih.gov/pubmed/35068861
http://dx.doi.org/10.3748/wjg.v27.i47.8166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704272/
https://www.ncbi.nlm.nih.gov/pubmed/35068861
http://dx.doi.org/10.3748/wjg.v27.i47.8166

Ejemplares similares